185 related articles for article (PubMed ID: 34916656)
1. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion.
Liu Y; Wang L; Song Q; Ali M; Crowe WN; Kucera GL; Hawkins GA; Soker S; Thomas KW; Miller LD; Lu Y; Bellinger CR; Zhang W; Habib AA; Petty WJ; Zhao D
Nat Nanotechnol; 2022 Feb; 17(2):206-216. PubMed ID: 34916656
[TBL] [Abstract][Full Text] [Related]
2. Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion.
Li X; Wu G; Chen C; Zhao Y; Zhu S; Song X; Yin J; Lv T; Song Y
Front Immunol; 2021; 12():760683. PubMed ID: 34966384
[TBL] [Abstract][Full Text] [Related]
3. Novel therapies for malignant pleural effusion: Anti‑angiogenic therapy and immunotherapy (Review).
He D; Ding R; Wen Q; Chen L
Int J Oncol; 2021 Mar; 58(3):359-370. PubMed ID: 33650668
[TBL] [Abstract][Full Text] [Related]
4. Engineered lactococcus lactis intrapleural therapy promotes regression of malignant pleural effusion by enhancing antitumor immunity.
Fan Y; Chen A; Zhu J; Liu R; Mei Y; Li L; Sha X; Wang X; Ren W; Wang L; Liu B
Cancer Lett; 2024 Apr; 588():216777. PubMed ID: 38432582
[TBL] [Abstract][Full Text] [Related]
5. A novel nano-immunotherapeutic remodels the immune landscape of malignant pleural effusion: Insights into its mechanism of action through single-cell RNA-sequencing.
Liu Y; Zhao D
Clin Transl Med; 2022 Mar; 12(3):e774. PubMed ID: 35297203
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutical effects of pleural injecting recombinant human endostain to
malignant pleural effusion nude mice model].
Zhou M; Li M; Yang H; Hu C
Zhongguo Fei Ai Za Zhi; 2015 May; 18(5):266-71. PubMed ID: 25975296
[TBL] [Abstract][Full Text] [Related]
7. Mutant KRAS promotes malignant pleural effusion formation.
Agalioti T; Giannou AD; Krontira AC; Kanellakis NI; Kati D; Vreka M; Pepe M; Spella M; Lilis I; Zazara DE; Nikolouli E; Spiropoulou N; Papadakis A; Papadia K; Voulgaridis A; Harokopos V; Stamou P; Meiners S; Eickelberg O; Snyder LA; Antimisiaris SG; Kardamakis D; Psallidas I; Marazioti A; Stathopoulos GT
Nat Commun; 2017 May; 8():15205. PubMed ID: 28508873
[TBL] [Abstract][Full Text] [Related]
8. Prolonged retention of liposomes in the pleural cavity of normal mice and high tumor distribution in mice with malignant pleural effusion, after intrapleural injection.
Marazioti A; Papadia K; Giannou A; Stathopoulos GT; Antimisiaris SG
Int J Nanomedicine; 2019; 14():3773-3784. PubMed ID: 31213801
[No Abstract] [Full Text] [Related]
9. Better effect of intrapleural perfusion with hyperthermic chemotherapy by video-assisted thoracoscopic surgery for malignant pleural effusion treatment compared to normothermic chemoperfusion of the pleural cavity.
Cao Y; Zhang Q; Huang Z; Chai Z; Liu J; Wang J; Sun Z; Zhao T; Wang G; Chen G; Han Y; Li Q; Hong X
Cancer Med; 2022 Jan; 11(2):348-357. PubMed ID: 34854253
[TBL] [Abstract][Full Text] [Related]
10. Mast cells mediate malignant pleural effusion formation.
Giannou AD; Marazioti A; Spella M; Kanellakis NI; Apostolopoulou H; Psallidas I; Prijovich ZM; Vreka M; Zazara DE; Lilis I; Papaleonidopoulos V; Kairi CA; Patmanidi AL; Giopanou I; Spiropoulou N; Harokopos V; Aidinis V; Spyratos D; Teliousi S; Papadaki H; Taraviras S; Snyder LA; Eickelberg O; Kardamakis D; Iwakura Y; Feyerabend TB; Rodewald HR; Kalomenidis I; Blackwell TS; Agalioti T; Stathopoulos GT
J Clin Invest; 2015 Jun; 125(6):2317-34. PubMed ID: 25915587
[TBL] [Abstract][Full Text] [Related]
11. Activated naïve B cells promote development of malignant pleural effusion by differential regulation of T
Wu XZ; Shi XY; Zhai K; Yi FS; Wang Z; Wang W; Pei XB; Xu LL; Wang Z; Shi HZ
Am J Physiol Lung Cell Mol Physiol; 2018 Sep; 315(3):L443-L455. PubMed ID: 29847991
[TBL] [Abstract][Full Text] [Related]
12. Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples.
Zou Y; Xu L; Tang Q; You Q; Wang X; Ding W; Zhao J; Ren G
BMC Cancer; 2020 Apr; 20(1):344. PubMed ID: 32321471
[TBL] [Abstract][Full Text] [Related]
13. Autologous tumor cell-derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion.
Guo M; Wu F; Hu G; Chen L; Xu J; Xu P; Wang X; Li Y; Liu S; Zhang S; Huang Q; Fan J; Lv Z; Zhou M; Duan L; Liao T; Yang G; Tang K; Liu B; Liao X; Tao X; Jin Y
Sci Transl Med; 2019 Jan; 11(474):. PubMed ID: 30626714
[TBL] [Abstract][Full Text] [Related]
14. Tumour cell PD-L1 expression is prognostic in patients with malignant pleural effusion: the impact of C-reactive protein and immune-checkpoint inhibition.
Ghanim B; Rosenmayr A; Stockhammer P; Vogl M; Celik A; Bas A; Kurul IC; Akyurek N; Varga A; Plönes T; Bankfalvi A; Hager T; Schuler M; Hackner K; Errhalt P; Scheed A; Seebacher G; Hegedus B; Stubenberger E; Aigner C
Sci Rep; 2020 Apr; 10(1):5784. PubMed ID: 32238865
[TBL] [Abstract][Full Text] [Related]
15. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
Stathopoulos GT; Psallidas I; Moustaki A; Moschos C; Kollintza A; Karabela S; Porfyridis I; Vassiliou S; Karatza M; Zhou Z; Joo M; Blackwell TS; Roussos C; Graf D; Kalomenidis I
J Natl Cancer Inst; 2008 Oct; 100(20):1464-76. PubMed ID: 18840818
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 Expression of Tumor Cells, Macrophages, and Immune Cells in Non-Small Cell Lung Cancer Patients with Malignant Pleural Effusion.
Tseng YH; Ho HL; Lai CR; Luo YH; Tseng YC; Whang-Peng J; Lin YH; Chou TY; Chen YM
J Thorac Oncol; 2018 Mar; 13(3):447-453. PubMed ID: 29246835
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients.
Zhang Z; Ji W; Huang J; Zhang Y; Zhou Y; Zhang J; Dong Y; Yuan T; Yang Q; Ding X; Tang L; Li H; Yin J; Wang Y; Ji T; Fei J; Zhang B; Chen P; Hu H
Clin Transl Med; 2022 Nov; 12(11):e1072. PubMed ID: 36305631
[TBL] [Abstract][Full Text] [Related]
18. Aerosolized immunotherapeutic nanoparticle inhalation potentiates PD-L1 blockade for locally advanced lung cancer.
Liu Y; Crowe WN; Wang L; Petty WJ; Habib AA; Zhao D
Nano Res; 2023 Apr; 16(4):5300-5310. PubMed ID: 37228440
[TBL] [Abstract][Full Text] [Related]
19. The Detection of Immunity against WT1 and SMAD4
Koya T; Niida Y; Togi M; Yoshida K; Sakamoto T; Ura H; Togi S; Kato T; Yamada S; Sugiyama H; Koido S; Shimodaira S
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293034
[TBL] [Abstract][Full Text] [Related]
20. Translational Nanotherapeutics Reprograms Immune Microenvironment in Malignant Pleural Effusion of Lung Adenocarcinoma.
Song Z; Luo W; Zheng H; Zeng Y; Wang J; Chen T
Adv Healthc Mater; 2021 Jun; 10(12):e2100149. PubMed ID: 33870649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
